Growth Metrics

Outlook Therapeutics (OTLK) Receivables - Other (2016)

Outlook Therapeutics (OTLK) has disclosed Receivables - Other for 2 consecutive years, with $43350.0 as the latest value for Q2 2016.

  • Quarterly Receivables - Other changed N/A to $43350.0 in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $43350.0 through Jun 2016, changed N/A year-over-year, with the annual reading at $117506.0 for FY2015, N/A changed from the prior year.
  • Receivables - Other for Q2 2016 was $43350.0 at Outlook Therapeutics, roughly flat from $43187.0 in the prior quarter.
  • The five-year high for Receivables - Other was $117506.0 in Q3 2015, with the low at $43187.0 in Q1 2016.